544312 Stock Overview

Provides pharmaceutical formulation, and freeze dried and frozen products in India and internationally. More details

544312 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	3/6
Financial Health	4/6
Dividends	0/6

Rewards

Earnings grew by 39.5% over the past year

Risk Analysis

High level of non-cash earnings

Makes less than USD$1m in revenue (₹65M)

Does not have a meaningful market cap (₹443M)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Hamps Bio Limited Competitors

Gujarat Terce Laboratories

BSE:524314

₹626.5m

Bacil Pharma

BSE:524516

₹361.1m

Medicamen Organics

NSEI:MEDIORG

₹658.7m

Shelter Pharma

BSE:543963

₹659.0m

Price History & Performance

Summary of share price highs, lows and changes for Hamps Bio
Historical stock prices
Current Share Price	₹101.74
52 Week High	₹101.74
52 Week Low	₹96.90
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	99.49%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	544312	IN Pharmaceuticals	IN Market
7D	n/a	0.8%	-4.2%
1Y	n/a	39.7%	19.1%

Return vs Industry: Insufficient data to determine how 544312 performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 544312 performed against the Indian Market.

Price Volatility

Is 544312's price volatile compared to industry and market?
544312 volatility
544312 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.0%
Market Average Movement	6.2%
10% most volatile stocks in IN Market	9.0%
10% least volatile stocks in IN Market	4.1%

Stable Share Price: 544312's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine 544312's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2007	73	Herrik Shah	hampsbio.com

Hamps Bio Limited provides pharmaceutical formulation, and freeze dried and frozen products in India and internationally. It offers pharmaceutical products in form of dosage, including tablets, syrups, capsules, injectables, and powder that are used as nutrition supplement, injections, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and anti-biotic/anti-bacterial/anti-fungal targeting orthopedic, physician, gynecologist, surgeon, dermatologist, etc. The company also provides freeze dried and frozen products. It offers its products under the HAMPS and FzyEzy brands through distribution network and e-commerce platform.

Hamps Bio Limited Fundamentals Summary

How do Hamps Bio's earnings and revenue compare to its market cap?
544312 fundamental statistics
Market cap	₹443.18m
Earnings (TTM)	₹5.01m
Revenue (TTM)	₹64.75m

88.5x

P/E Ratio

6.8x

P/S Ratio

Is 544312 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
544312 income statement (TTM)
Revenue	₹64.75m
Cost of Revenue	₹18.12m
Gross Profit	₹46.64m
Other Expenses	₹41.63m
Earnings	₹5.01m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.15
Gross Margin	72.02%
Net Profit Margin	7.73%
Debt/Equity Ratio	31.0%

How did 544312 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 02:08
End of Day Share Price	2024/12/20 00:00
Earnings	2024/03/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hamps Bio Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution